β Home
βΉοΈ Info
π§Ύ Overview π Core Facts π₯ Video Insights β Ratings π§βπΌ Executives π¬ My Commentsπ‘ Analytics
π’ Company Q&A π οΈ Industry Q&A π Competitors π Stock Swings β‘ SWOT ποΈ PEST π Porter's Five Forces β¨ Score Positive β οΈ Risks π§© Segmentationπ§ Tools
β Due DiligenceFinancial Ratios
Pay attention and research significant changes from year to year values. [ ! ]
Fixed Column | Current Ratio | Quick Ratio | Cash Ratio | Days Of Sales Outstanding | Days Of Inventory Outstanding | Operating Cycle | Days Of Payables Outstanding | Cash Conversion Cycle | Gross Profit Margin | Operating Profit Margin | Pretax Profit Margin | Net Profit Margin | Effective Tax Rate | Return On Assets | Return On Equity | Return On Capital Employed | Net Income Per EBT | EBT Per EBIT | EBIT Per Revenue | Debt Ratio | Debt/Equity Ratio | Long Term Debt To Capitalization | Total Debt To Capitalization | Interest Coverage | Cash Flow To Debt Ratio | Company Equity Multiplier | Receivables Turnover | Payables Turnover | Inventory Turnover | Fixed Asset Turnover | Asset Turnover | Operating Cash Flow Per Share | Free Cash Flow Per Share | Cash Per Share | Payout Ratio | Operating Cash Flow / Sales Ratio | Free Cash Flow / Operating Cash Flow Ratio | Cash Flow Coverage Ratio | Short Term Coverage Ratios | Capital Expenditure Coverage Ratio | Dividend Paid And CAPEX Coverage Ratio | Dividend Payout Ratio | Price Book Value Ratio | Price To Book Ratio | Price To Sales Ratio | Price Earnings Ratio | Price To Free Cash Flows Ratio | Price To Operating Cash Flows Ratio | Price Cash Flow Ratio | Price Earnings To Growth Ratio | Price Sales Ratio | Dividend Yield | Enterprise Value Multiple | Price Fair Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-12 | 0.72 | 0.18 | 0.1 | 0 | 1605.25 | 1605.25 | 260.38 | 1344.87 | 0.74 | 0.5 | 0.37 | 0.36 | 0.01 | 0.02 | 0.03 | 0.03 | 0.99 | 0.73 | 0.5 | 0.38 | 0.64 | 0.34 | 0.39 | 4.72 | 0.09 | 1.71 | 0 | 1.4 | 0.23 | 9.4 | 0.05 | 8.11 | 1.96 | 2.42 | 1.27 | 0.7 | 0.24 | 0.09 | 0.43 | 1.32 | 0.71 | 1.27 | 0.62 | 0.62 | 7.64 | 21.06 | 44.93 | 10.87 | 10.87 | -0.18 | 7.64 | 0.06 | 31.61 | 0.62 |
2023-12 | 0.47 | 0.29 | 0.14 | 14.08 | 287.73 | 301.81 | 76.39 | 225.43 | 0.72 | -1.93 | -2.14 | -2.14 | -0 | -0.1 | -0.17 | -0.1 | 1 | 1.11 | -1.93 | 0.36 | 0.61 | 0.35 | 0.38 | -18.31 | 0.08 | 1.67 | 25.92 | 4.78 | 1.27 | 0.05 | 0.05 | 7.24 | 1.96 | 2.08 | -0.22 | 0.64 | 0.27 | 0.08 | 0.89 | 1.37 | 0.68 | -0.22 | 0.77 | 0.77 | 9.7 | -4.54 | 56.14 | 15.16 | 15.16 | 0 | 9.7 | 0.05 | -8.51 | 0.77 |
2022-12 | 0.18 | 0.09 | 0.02 | 15.9 | 417.14 | 433.04 | 54.04 | 378.99 | 0.76 | 0.27 | 0.22 | 0.22 | 0.02 | 0.01 | 0.01 | 0.01 | 0.99 | 0.83 | 0.27 | 0.35 | 0.57 | 0.3 | 0.36 | 2.16 | 0.07 | 1.62 | 22.96 | 6.75 | 0.88 | 0.51 | 0.04 | 6.56 | 1.56 | -249.59 | 2.31 | 0.63 | 0.24 | 0.07 | 0.25 | 1.31 | 0.64 | 2.31 | 0.37 | 0.37 | 6.13 | 27.66 | 40.8 | 9.7 | 9.7 | -0.35 | 6.13 | 0.08 | 45.18 | 0.37 |
2021-12 | 0.19 | 0.09 | 0.01 | 19.02 | 418.24 | 437.26 | 62.19 | 375.07 | 0.76 | 1.26 | 1.13 | 1.12 | 0 | 0.04 | 0.07 | 0.05 | 1 | 0.9 | 1.26 | 0.34 | 0.54 | 0.29 | 0.35 | 10.68 | 0.07 | 1.58 | 19.19 | 5.87 | 0.87 | 0.44 | 0.04 | 6.54 | 1.64 | -245.5 | 0.46 | 0.64 | 0.25 | 0.07 | 0.28 | 1.34 | 0.64 | 0.46 | 0.73 | 0.73 | 12.52 | 11.14 | 78.14 | 19.63 | 19.63 | 0.02 | 12.52 | 0.04 | 17.21 | 0.73 |
2020-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2019-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2018-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2017-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2016-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2015-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2014-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |

π Explore more ratios for Gecina!
Sign up for free or log inπ Get insights from "The Checklist Value Investor β A Smarter Way to Pick Stocks" now!